Trial Profile
The efficacy of CASAD in patients with diarrhea related to medullary thyroid cancer: a pilot study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Calcium aluminium silicate (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- Sponsors Salient Pharmaceuticals
- 17 Jun 2014 New trial record